Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analyses Meeting Abstract
| Authors: | Tamura, K.; Modi, S.; Tsurutani, J.; Takahashi, S.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; Zhang, L.; Lee, C.; Yver, A.; Baselga, J. |
| Abstract Title: | Dose justification for DS-8201a, a HER2-targeted antibody-drug conjugate, for HER2-positive breast cancer: Observed clinical data and exposure-response analyses |
| Meeting Title: | 41st Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Dec 4-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000478677002278 |
| DOI: | 10.1158/1538-7445.Sabcs18-p6-17-10 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P6-17-10 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work